Wif1 is a frequent target for epigenetic silencing in squamous cell carcinoma of the cervix

Carcinogenesis

Volumn 32, Issue 11, 2011, Pages 1625-1633

  Delmas, Amber L ^a   Riggs, Bridget M ^b   Pardo, Carolina E ^a   Dyer, Lisa M ^a   Darst, Russell P ^a   Izumchenko, Eugene G ^a   Monroe, Mänette ^c   Hakam, Ardeshir ^b   Kladde, Michael P ^a   Siegel, Erin M ^b   Brown, Kevin D ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; GENE PRODUCT; WNT PROTEIN;

ARTICLE; CHROMATIN STRUCTURE; CONTROLLED STUDY; DNA FOOTPRINTING; EPIGENETICS; GENE; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROMOTER REGION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; WIF1 GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AZACITIDINE; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE; CERVIX UTERI; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; IMMUNOENZYME TECHNIQUES; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UTERINE CERVICAL NEOPLASMS;

EID: 80755144044     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr193     Document Type: Article

References (62)

1. Walboomers, J.M. et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol., 189, 12-19.
2. Morris, S.M. et al. (1998) p53, mutations, and apoptosis in genisteinexposed human lymphoblastoid cells. Mutat. Res., 405, 41-56.
3. Subramanya, D. et al. (2008) HPVand cervical cancer: updates on an established relationship. Postgrad. Med., 120, 7-13.
4. Jones, P.A. et al. (2007) The epigenomics of cancer. Cell, 128, 683-692.
5. Nusse, R. et al. (1982) Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell, 31, 99-109.
6. Peifer, M. et al. (2000) Wnt signaling in oncogenesis and embryogenesis-a look outside the nucleus. Science, 287, 1606-1609.
7. Polakis, P. (2000) Wnt signaling and cancer. Genes Dev., 14, 1837-1851.
8. He, T.C. et al. (1998) Identification of c-MYC as a target of the APC pathway. Science, 281, 1509-1512.
9. Wu, K.J. et al. (1999) Direct activation of TERT transcription by c-MYC. Nat. Genet., 21, 220-224.
10. Kawano, Y. et al. (2003) Secreted antagonists of the Wnt signalling pathway. J. Cell. Sci., 116, 2627-2634.
11. Li, X. et al. (2005) Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J. Biol. Chem., 280, 19883-19887.
12. Itasaki, N. et al. (2003)Wise, a context-dependent activator and inhibitor of Wnt signalling. Development, 130, 4295-4305.
13. Szalmas, A. et al. (2009) Epigenetic alterations in cervical carcinogenesis. Semin. Cancer Biol., 19, 144-152.
14. Kiyono, T. et al. (1997) Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc. Natl Acad. Sci. USA, 94, 11612-11616.
15. Lee, S.S. et al. (1997) Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proc. Natl Acad. Sci. USA, 94, 6670-6675.
16. Nakagawa, S. et al. (2000) Human scribble (Vartul) is targeted for ubiquitinmediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol. Cell. Biol., 20, 8244-8253.
17. Mantovani, F. et al. (2001) Proteasome-mediated regulation of the hDlg tumour suppressor protein. J. Cell. Sci., 114, 4285-4292.
18. Handa, K. et al. (2007) E6AP-dependent degradation of DLG4/PSD95 by high-risk human papillomavirus type 18 E6 protein. J. Virol., 81, 1379-1389.
19. Kuballa, P. et al. (2007) The role of the ubiquitin ligase E6-AP in human papillomavirus E6-mediated degradation of PDZ domain-containing proteins. J. Biol. Chem., 282, 65-71.
20. Lichtig, H. et al. (2010) HPV16 E6 augments Wnt signaling in an E6APdependent manner. Virology, 396, 47-58.
21. Matsumine, A. et al. (1996) Binding of APC to the human homolog of the Drosophila discs large tumor suppressor protein. Science, 272, 1020-1023.
22. Ishidate, T. et al. (2000) The APC-hDLG complex negatively regulates cell cycle progression from the G0/G1 to S phase. Oncogene, 19, 365-372.
23. Takizawa, S. et al. (2006) Human scribble, a novel tumor suppressor identified as a target of high-risk HPV E6 for ubiquitin-mediated degradation, interacts with adenomatous polyposis coli. Genes Cells, 11, 453-464.
24. Zhan, L. et al. (2008) Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma. Cell, 135, 865-878.
25. Hsieh, J.C. et al. (1999) A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature, 398, 431-436.
26. Ai, L. et al. (2006) Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer. Carcinogenesis, 27, 1341-1348.
27. Urakami, S. et al. (2006) Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/ beta-catenin signaling pathway. Clin. Cancer Res., 12, 383-391.
28. Roman-Gomez, J. et al. (2007) Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia. Blood, 109, 3462-3469.
29. Chan, S.L. et al. (2007) The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas. Lab. Invest., 87, 644-650.
30. Mazieres, J. et al. (2004) Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res., 64, 4717-4720.
31. Licchesi, J.D. et al. (2010) Transcriptional regulation of Wnt inhibitory factor-1 by Miz-1/c-Myc. Oncogene, 29, 5923-5934.
32. Ai, L. et al. (2006) Epigenetic silencing of the tumor suppressor Cystatin M occurs during breast cancer progression. Cancer Res., 66, 7899-7909.
33. Darst, R.P. et al. (2010) Bisulfite sequencing of DNA. Curr. Protoc. Mol. Biol., Chapter 7, Unit 7. 9, 1-17.
34. Demircan, B. et al. (2009) Comparative epigenomics of human and mouse mammary tumors. Genes Chromosomes Cancer, 48, 83-97.
35. Adamson, A.W. et al. (2002) ATM is activated in response to MNNG-induced DNA alkylation. J. Biol. Chem., 31, 31.
36. Pardo, C.E. et al. (2010) MethylViewer: computational analysis and editing for bisulfite sequencing and methyltransferase accessibility protocol for individual templates (MAPit) projects. Nucleic Acids Res., 39, e5.
37. Frommer, M. et al. (1992) A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl Acad. Sci. USA, 89, 1827-1831.
38. Colella, S. et al. (2003) Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. Biotechniques, 35, 146-150.
39. Datta, J. et al. (2009) A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation. Cancer Res., 69, 4277-4285.
40. Issa, J.P. et al. (2009) Targeting DNA methylation. Clin. Cancer Res., 15, 3938-3946.
41. Jessen, W.J. et al. (2006) Active PHO5 chromatin encompasses variable numbers of nucleosomes at individual promoters. Nat. Struct. Mol. Biol., 13, 256-263.
42. Pardo, C. et al. (2009) DNA methyltransferase probing of chromatin structure within populations and on single molecules. Methods Mol. Biol., 523, 41-65.
43. Xu, M. et al. (1998) Cloning, characterization and expression of the gene coding for a cytosine-5-DNA methyltransferase recognizing GpC. Nucleic Acids Res., 26, 3961-3966.
44. Hoose, S.A. et al. (2006) DNA methyltransferase probing of DNA-protein interactions. Methods Mol. Biol., 338, 225-244.
45. Pondugula, S. et al. (2008) Single-molecule analysis of chromatin: changing the view of genomes one molecule at a time. J. Cell. Biochem., 105, 330-337.
46. Liu, J. et al. (2008) Adiponectin stimulates Wnt inhibitory factor-1 expression through epigenetic regulations involving the transcription factor specificity protein 1. Carcinogenesis, 29, 2195-2202.
47. Smale, S.T. et al. (1989) The "initiator" as a transcription control element. Cell, 57, 103-113.
48. Peukert, K. et al. (1997) An alternative pathway for gene regulation by Myc. EMBO J., 16, 5672-5686.
49. Macleod, D. et al. (1994) Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev., 8, 2282-2292.
50. Brandeis, M. et al. (1994) Sp1 elements protect a CpG island from de novo methylation. Nature, 371, 435-438.
51. Gal-Yam, E.N. et al. (2006) Constitutive nucleosome depletion and ordered factor assembly at the GRP78 promoter revealed by single molecule footprinting. PLoS Genet., 2, e160.
52. Dechassa, M.L. et al. (2010) SWI/SNF has intrinsic nucleosome disassembly activity that is dependent on adjacent nucleosomes. Mol. Cell., 38, 590-602.
53. Ueda, M. et al. (2001) Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. Br. J. Cancer, 85, 64-68.
54. Uren, A. et al. (2005) Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression. Cancer Res., 65, 6199-6206.
55. Rodriguez-Sastre, M.A. et al. (2005) Abnormal distribution of E-cadherin and beta-catenin in different histologic types of cancer of the uterine cervix. Gynecol. Oncol., 97, 330-336.
56. Pereira-Suarez, A.L. et al. (2002) Frequent alterations of the beta-catenin protein in cancer of the uterine cervix. Tumour Biol., 23, 45-53.
57. Imura, J. et al. (2001) Beta-catenin expression as a prognostic indicator in cervical adenocarcinoma. Int. J. Mol. Med., 8, 353-358.
58. Miller, C. et al. (1998) Differential expression patterns of Wnt genes in the murine female reproductive tract during development and the estrous cycle. Mech. Dev., 76, 91-99.
59. Vainio, S. et al. (1999) Female development in mammals is regulated by Wnt-4 signalling. Nature, 397, 405-409.
60. Carroll, T.J. et al. (2005) Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system. Dev. Cell, 9, 283-292.
61. Parr, B.A. et al. (1998) Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a. Nature, 395, 707-710.
62. Carta, L. et al. (2004) Wnt7a is a suppressor of cell death in the female reproductive tract and is required for postnatal and estrogen-mediated growth. Biol. Reprod., 71, 444-454.